Johnson & Johnson today honors the winners of the 2012 Dr. Paul Janssen Award for Biomedical Research in a ceremony and scientific symposium at the New York Academy of Sciences in New York, NY. Victor Ambros, Ph.D., of the University of Massachusetts Medical School, and Gary Ruvkun, Ph.D., of Massachusetts General Hospital and Harvard Medical School, received the award for their collaborative discovery of microRNAs (miRNAs) as central regulators of gene expression and development, and will share a $100,000 prize.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58019-johnson-and-johnson-jnj-2012-dr-paul-janssen-award-for-biomedical-research
Surmang Foundation has operated a primary care clinic in a remote, poor region of Western China, in partnership with the Chinese Government, Qinghai Province, and Yushu Prefecture, since 1992. The Core Project has treated over 60,000 patients for free, including medicine, since the clinic building was completed in 1996. Its focus is on the maternal and child mortality/morbidity rates of the region, among the highest in the world. It supports two local ethnic Tibetan doctors, Phuntsok Dongdrup and Sonam Drogha.
In our catchment area, the average annual income is about $50. Surmang Foundation’s remote site is a test case and a model for all of rural China, because impoverished nomadic Tibetans manifest in the extreme, most rural health and poverty problems. In cooperation with the Chinese Government and several hospitals, Surmang Foundation is currently expanding its mission to address the lack of access to basic services among the 28 million impoverished residents of rural, Western China and the lack of capacity of the local medical providers.
The pilot project will create a network of remote providers for IT-based distance medical education and remote diagnosis and referral. The pilot began in 2005 with the promulgation of an archive of all Tibetan and Chinese language health promotion materials and continued in 2006 with the installation of a satellite dish at the Surmang campus.
A part of that is the Community Health Worker Project funded by an AmCham grant in Spring 2005.
Surmang Foundation has partnered with the Soong Ching-ling Foundation since November 2005.
Poor children in the Dominican Republic will now have a chance at a better life through Children International, a U.S.-based humanitarian organization, thanks to businessman Larry Phelan.
The Philadelphia attorney funded the newly inaugurated signature community center that will serve 5,000 children in the slum of La Caleta near Santo Domingo. The center will provide children access to medical and dental care, education support, and nutritional programs.
Mr. Phelan was inspired to work with Children International by his friend Dan Phelan, who funded another center in the Dominican Republic. Much like Dan’s facility, the Larry T. Phelan Community Center is state-of-the-art, with a medical clinic, dental clinic, pharmacy, library, playground, computer lab and a sports complex.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52274-children-international-larry-t-phelan-community-center-la-caleta
Invacare Corporation (NYSE:IVC), the global leader in home and long-term care medical products, today is launching “Real Life,” a new campaign dedicated to raising awareness of the everyday struggles and achievements of those living with disabilities, ailments or advancing age. For these individuals, even “ordinary” tasks like getting dressed, preparing for the day ahead, caring for children, driving a car or going to work can require extraordinary effort — yet few people are aware of these everyday struggles and achievements. Invacare has created this awareness campaign and platform so that people can share their ‘real life’ stories — or the story of someone who inspires them — for a chance to win cash prizes for themselves and the charity of their choice.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/invacare/49159/
On May 27, CVS/pharmacy launched a new in-store fundraising campaign named Advancing Medical Research, to support medical research and help improve the quality of life for those living with amyotrophic lateral sclerosis (ALS) and cystic fibrosis (CF). Funds raised through the campaign will benefit the ALS Therapy Alliance (ATA), a leading organization dedicated to advancing ALS research, and the Cystic Fibrosis Foundation, the world’s leader in the search for a cure for cystic fibrosis. Supporters for the 2012 campaign can donate $1 or $3 dollars at the register in CVS/pharmacy locations and online at www.cvs.com/alscff through June 30.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56330-cvs-pharmacy-fundraising-campaign-support-als-and-cystic-fibrosis
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for the BD Veritor™ System for rapid detection of Flu A+B. This is the first rapid influenza test system that incorporates a digital read out of results to receive CLIA waiver.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53615-bd-veritor-system-influenza-test-receives-510k-clearance-fda-clia-waiver
Frost & Sullivan honors KJAYA Medical with the Frost & Sullivan 2011 North American Technology Innovation Award in Web-based Medical Imaging Data Management for its innovative VoXcell® Imaging Suite. For the first time, medical facilities can manage all imaging workflow throughout the enterprise using robust industry-standard applications, leading-edge 3D processing, PET/CT analysis and more – all with on-demand anywhere, anytime Internet availability.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/frostsullivan/53330/
Designed to help developers obtain safety certifications, Texas Instruments Incorporated (TI) (NYSE: TXN) today announced its new Hercules safety microcontroller platform for medical, industrial and transportation applications. The platform consists of three ARM Cortex-based microcontroller families that deliver scalable performance, connectivity, memory and safety features for applications that require a high level of reliability. Unlike many microcontrollers that rely heavily on software for safety capabilities, Hercules microcontrollers implement safeguards in hardware to maximize performance and reduce software overhead. Coupled with robust tools, software and safety documentation, this functionality gives developers the headroom to differentiate their end products and speed time to market. For more information, visit www.ti.com/hercules-pr-lp.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/texasinstruments/39162/
Living Proof, founded by bio-medical scientists with the sole mission to engineer solutions to the world’s toughest beauty problems, has created a breakthrough solution for dry, damaged hair – Restore. To prove that you can undo the damage and transform your hair in just 14 days with Restore, Living Proof is kicking off a campaign asking women to embark on a 14-Day “Restore the Love” Challenge on Facebook with a chance to win a Canyon Ranch Vacation.
To begin their campaign to restore as many women’s hair as possible, Living Proof brought a “Restore the Love” Bus to New York City this past weekend (May 18 – 20) to encourage women to get on board the Restore 14-Day Challenge. This one-of-a-kind experience featured hair consultations with celebrity hair stylist and Living Proof Creative Director Tim Rogers, founding hair stylist Mitch De Rosa, and Living Proof’s elite group of scientists. Throughout the weekend, women were encouraged to restore the love for their hair and prove that they can undo the damage and transform hair in just two weeks.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56350-living-proof-restore-the-love-challenge
“Explore Your Treatment Options,” a new multimedia ad campaign announced today by the U.S. Department of Health and Human Services’ Agency for Healthcare Research and Quality (AHRQ) and the Ad Council, encourages patients to become more informed about their options before choosing a treatment for a health condition or illness.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/50583/
